Department of Internal Medicine, Ascension Saint Joseph Hospital, Chicago, Illinois.
Department of Internal Medicine, Ascension Saint Joseph Hospital, Chicago, Illinois.
Am J Cardiol. 2024 Jul 1;222:65-71. doi: 10.1016/j.amjcard.2024.04.026. Epub 2024 Apr 18.
Despite a 30% decrease in the rate over the last decade, coronary artery bypass graft (CABG) surgery remains a common major surgical procedure with significant morbidity and mortality. Chronic liver disease (CLD) patients, with increased survival rates because of medical advancements, are now frequently being considered for CABG, bearing higher perioperative risks. This study investigates the association between CLD and in-hospital outcomes in CABG patients using retrospective data from the National Inpatient Sample database (2016 to 2020) including 7,945 CLD patients who underwent CABG that were propensity score-matched with an equivalent number of patients without CLD who underwent CABG. Clinical variables were extracted using corresponding International Classification of Diseases, Tenth Revision codes, and multivariable logistic and linear regression models were used to assess in-hospital mortality, complications, and length of stay. The overall mortality rate was 5.5% (8.6% in the CLD group with cirrhosis, 5.9% CLD group without cirrhosis, and 2.8% in the non-CLD group, p <0.001). CLD with cirrhosis was associated with higher odds of mortality (adjusted odds ratio = 4.21, 95% confidence interval 3.61 to 4.94) and length of stay (β = 1.03, 95% confidence interval 1.01 to 1.05). CLD patients with cirrhosis demonstrated higher odds of perioperative cardiac complications (cardiac arrest, ventricular arrhythmias, tamponade, and shock), thromboembolic events, gastrointestinal bleeding, bowel ischemia, acute kidney injury, pneumonia, and sepsis. This study reveals a substantial impact of CLD on adverse outcomes in CABG patients, emphasizing the need for tailored preoperative assessments and postoperative care.
尽管过去十年的发病率下降了 30%,但冠状动脉旁路移植术(CABG)仍然是一种常见的主要手术,具有显著的发病率和死亡率。由于医疗技术的进步,慢性肝病(CLD)患者的生存率提高,现在经常被考虑进行 CABG,但他们围手术期的风险更高。本研究使用国家住院患者样本数据库(2016 年至 2020 年)的回顾性数据,调查了 CLD 与 CABG 患者住院期间结局的关系,该数据库包括 7945 例接受 CABG 的 CLD 患者,他们与接受 CABG 的数量相等的无 CLD 患者进行了倾向评分匹配。使用相应的国际疾病分类,第十版代码提取临床变量,并使用多变量逻辑和线性回归模型评估住院死亡率、并发症和住院时间。总体死亡率为 5.5%(肝硬化组为 8.6%,非肝硬化组为 5.9%,非 CLD 组为 2.8%,p<0.001)。肝硬化合并 CLD 与死亡率升高相关(调整后比值比=4.21,95%置信区间 3.61 至 4.94)和住院时间延长(β=1.03,95%置信区间 1.01 至 1.05)。肝硬化合并 CLD 的患者围手术期心脏并发症(心脏骤停、室性心律失常、心脏压塞和休克)、血栓栓塞事件、胃肠道出血、肠缺血、急性肾损伤、肺炎和败血症的发生风险更高。本研究揭示了 CLD 对 CABG 患者不良结局的重大影响,强调了需要进行个性化的术前评估和术后护理。